CGCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
Canopy Growth Corp
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.72+0.00 (+0.38%)
Close on Oct 19, 2026
Canopy Growth Corp revenue by segment
By business segment
| Revenue | Q1 27 | Q4 26 | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Canada Cannabis | C$65.09M | – | C$51.65M | C$50.85M | C$5.70M | C$14.64M | C$49.70M | C$45.42M | C$46.09M | C$38.62M | C$40.38M | C$40.27M | 80.2% | +1042.2% |
| Cannabis Net Revenue | C$65.09M | C$54.46M | C$51.65M | C$50.85M | C$56.98M | C$45.51M | C$49.70M | C$45.42M | C$46.09M | – | – | – | 80.2% | +14.2% |
| Storz & Bickel | C$16.08M | C$16.78M | C$22.89M | C$15.83M | C$15.15M | C$19.52M | C$25.06M | C$17.57M | C$20.12M | C$30.95M | C$18.45M | C$11.99M | 19.8% | +6.1% |
| Canadian adult-use Cannabis Net Revenue | – | – | – | – | – | – | – | – | – | C$20.78M | C$23.39M | C$24.02M | – | – |
| Canadian Medical Cannabis Net Revenue | – | – | – | – | – | – | – | – | – | C$16.30M | C$15.64M | C$14.98M | – | – |
| Rest-of-world Cannabis | – | – | – | – | – | – | – | – | – | – | C$10.53M | C$8.98M | – | – |
| This Works | – | – | – | – | – | – | – | – | – | C$0 | C$8.17M | C$7.07M | – | – |
| Canadian Cannabis Net Revenue | – | – | – | – | – | C$40.38M | C$40.73M | C$37.08M | C$37.68M | C$38.62M | C$40.38M | C$40.27M | – | – |
| Other | – | – | – | – | – | – | – | – | – | C$367.00K | C$976.00K | C$1.29M | – | – |
| International Markets Cannabis | – | – | – | – | – | C$7.57M | C$12.02M | C$10.06M | C$10.08M | C$11.65M | C$10.53M | C$8.98M | – | – |
By product or service
| Revenue | Q1 27 | Q4 26 | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Storz & Bickel | C$16.08M | C$16.78M | C$22.89M | C$15.83M | C$15.15M | C$19.52M | C$25.06M | C$17.57M | C$20.12M | C$30.95M | C$18.45M | C$11.99M | 19.8% | +6.1% |
| International Markets Cannabis | C$9.60M | C$8.60M | C$6.21M | C$5.09M | C$8.76M | C$5.13M | C$8.97M | C$8.35M | C$8.42M | C$2.85M | C$10.53M | C$8.98M | 11.8% | +9.6% |
| This Work | – | – | – | – | – | – | – | – | – | C$0 | C$8.17M | C$7.07M | – | – |
| Other | – | – | – | – | – | – | – | – | – | C$367.00K | C$976.00K | C$1.29M | – | – |
By region
| Revenue | Q1 27 | Q4 26 | Q3 26 | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Canada | C$54.94M | C$46.67M | C$45.44M | C$45.76M | C$48.23M | C$40.43M | C$40.73M | C$37.08M | C$37.68M | C$38.99M | C$41.02M | C$41.17M | 67.7% | +13.9% |
| Germany | C$17.59M | C$15.77M | C$19.20M | C$12.73M | C$14.38M | C$12.45M | C$17.74M | C$14.21M | C$15.51M | C$16.91M | C$13.46M | C$10.08M | 21.7% | +22.3% |
| United States | C$6.23M | C$7.25M | C$8.67M | C$6.37M | C$5.97M | C$8.48M | C$11.56M | C$7.34M | C$8.62M | C$12.89M | C$10.33M | C$6.13M | 7.7% | +4.3% |
| Other | C$2.41M | C$1.56M | C$1.23M | C$1.83M | C$3.55M | C$3.68M | C$4.74M | C$4.37M | C$4.41M | C$4.01M | C$13.69M | C$12.22M | 3.0% | -32.3% |
From the segment and revenue-disaggregation notes of Canopy Growth's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.